December 22, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced the first patient cases with the investigational Dual Energy Thermocool SmartTouch SF Catheter took place as part of the SmartPulse pivotal study for treatment of paroxysmal

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, announced the successful implantation of its Topaz transfemoral tricuspid heart valve replacement system (“Topaz”) in a patient with a pacemaker at the University Medical Center of Mainz, Germany.

December 20, 2023 — Staten Island University Hospital (SIUH), part of Northwell Health, proudly announces its inclusion among the select few hospitals in Northwell Health to achieve the coveted three-star overall quality ratings by the Society of Thoracic Surgeons (STS) for its outstanding cardiothoracic surgery program. This prestigious recognition places SIUH in the top echelons of surgical excellence. 

Download the Diagnostic and Interventional Cardiology/DAIC Media Kit now to help plan your marketing campaigns for 2024.

 

You’ll get a look at our imaging audience, the editorial calendar, rates and descriptions of all our new and proven products to help you maximize your reach to the complete buying team for interventional cardiology.

December 19, 2023 — A vest that can map the electrical activity of the heart in fine detail could potentially be used to better identify people at high risk of sudden cardiac death, suggests a new study led by UCL researchers.

Electrical signals trigger our hearts to contract, regulating our heartbeat. Problems with these signals result in heart rhythm disorders, experienced by two million people in the UK, and can cause sudden death.

December 19, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, announced that the first patient was enrolled and treated in its CardiALLO Allogeneic Mesenchymal Cell Therapy Phase I/II trial for the treatment of patients with New York Heart Association Class II and III ischemic heart failure of reduced ejection fraction (

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro.Pulse, a dual-source computed tomography scanner designed to be more affordable for a wide range of healthcare facilities, including outpatient diagnostic centers.

December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective, feasibility clinical trial, resulting in a statistically significant 91.2% predictive accuracy for the determination of apnea-hypopnea index (AHI) for diagnosing obstructive sleep apnea (OSA) while using the Peerbridge Cor.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now